Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 19:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Announces Pricing of Initial Public Offering

ALISO VIEJO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial...
February 04, 2026 19:59 ET | Source: Eikon Therapeutics, Inc.

Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering

MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to...
February 04, 2026 16:58 ET | Source: Cipher Mining Inc.

Cipher Mining Inc. Announces Pricing of $2.0 Billion of Senior Secured Notes

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leading developer and operator of industrial-scale data centers, today announced that its...
February 03, 2026 06:30 ET | Source: ARKO CORP.

ARKO Corp. Announces Launch of Initial Public Offering of its Subsidiary, ARKO Petroleum Corp., Seeking to Raise Approximately $200,000,000

RICHMOND, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”) today announced that its subsidiary, ARKO Petroleum Corp. (“APC”), has launched a roadshow for...
February 02, 2026 16:05 ET | Source: Vaxcyte, Inc.

Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN CARLOS, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, announced today the closing of its previously announced underwritten...
February 02, 2026 08:30 ET | Source: Polaryx Therapeutics, Inc.

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

PARAMUS, NJ, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics (“Polaryx” or the “Company”) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization...
February 02, 2026 07:00 ET | Source: AgomAb Therapeutics N.V.

Agomab Announces Launch of Initial Public Offering

Agomab today announced the launch of its initial public offering of 12,500,000 ADSs pursuant to a registration statement filed with the SEC.
February 02, 2026 01:42 ET | Source: BCKD

BCKD Capital and SVCV Announce Listing Plans in Tokyo and Hong Kong Ahead of Its First Fund

New York City, Feb. 02, 2026 (GLOBE NEWSWIRE) -- BCKD Capital (“BCKD” / “The Firm”), a newly relaunched global hybrid financial firm based in New York City and Tokyo, is announcing its listing plans...
January 30, 2026 16:15 ET | Source: Xsolla SPAC 1

Xsolla SPAC 1 Announces Closing of $200,000,000 Initial Public Offering

Sherman Oaks, CA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Xsolla SPAC 1 (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced...
January 30, 2026 07:00 ET | Source: KRAKacquisition Corp

KRAKacquisition Corp Announces Closing of Upsized $345 Million Initial Public Offering and Full Exercise of Over-Allotment Option

Cheyenne, WY, USA, Jan. 30, 2026 (GLOBE NEWSWIRE) -- KRAKacquisition Corp (the “Company”), a special purpose acquisition company sponsored by an affiliate of Natural Capital, Tribe Capital, and...